Volume 10, issue 1, December 2017
175 articles in this issue
-
-
-
Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targets
Authors (first, second and last of 10)
-
AC-93253 iodide, a novel Src inhibitor, suppresses NSCLC progression by modulating multiple Src-related signaling pathways
Authors (first, second and last of 5)
-
Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)
Authors (first, second and last of 12)
-
Role of AP-2α and MAPK7 in the regulation of autocrine TGF-β/miR-200b signals to maintain epithelial-mesenchymal transition in cholangiocarcinoma
Authors (first, second and last of 7)
-
Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis
Authors (first, second and last of 5)
-
A comprehensive data mining study shows that most nuclear receptors act as newly proposed homeostasis-associated molecular pattern receptors
Authors (first, second and last of 23)
-
-
-
The crosstalk between autophagic and endo-/exosomal pathways in antigen processing for MHC presentation in anticancer T cell immune responses
Authors (first, second and last of 8)
-
-
Erratum to: MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis
Authors (first, second and last of 12)
-
An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemia
Authors (first, second and last of 12)
-
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells
Authors (first, second and last of 21)
-
Erratum to: Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test
Authors (first, second and last of 10)
-
The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis
Authors (first, second and last of 13)
-
Association of a novel point mutation in MSH2 gene with familial multiple primary cancers
Authors (first, second and last of 8)
-
-
Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses
Authors (first, second and last of 14)
-
-
Erratum to: Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial
Authors (first, second and last of 8)
-
Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study
Authors (first, second and last of 18)
-
Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test
Authors (first, second and last of 10)
-
Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
Authors (first, second and last of 8)
This is part of 1 collection:
-
Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia
Authors (first, second and last of 4)
-
-
Transcriptome sequencing in pediatric acute lymphoblastic leukemia identifies fusion genes associated with distinct DNA methylation profiles
Authors (first, second and last of 14)
-
-
PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy
Authors (first, second and last of 10)
-
-
-
Erratum to: Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell proliferation by epigenetic silencing of KLF2
Authors (first, second and last of 10)
-
Recent developments in immunotherapy of acute myeloid leukemia
Authors (first, second and last of 5)
This is part of 1 collection:
-
Metabolism-associated danger signal-induced immune response and reverse immune checkpoint-activated CD40+ monocyte differentiation
Authors (first, second and last of 11)
-
miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an “ALT-like” phenotype in diffuse malignant peritoneal mesothelioma cells
Authors (first, second and last of 6)
-
The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse model
Authors (first, second and last of 12)
-
Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia
Authors (first, second and last of 11)
-
Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study
Authors (first, second and last of 21)
-
Ongoing clinical trials of PD-1 and PD-L1 inhibitors for lung cancer in China
Authors
This is part of 1 collection:
-
Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia
Authors (first, second and last of 13)
-
Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis
Authors (first, second and last of 15)
-
MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
Authors (first, second and last of 5)
-
The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis
Authors (first, second and last of 11)
-
Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q)
Authors (first, second and last of 18)
-
Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
Authors (first, second and last of 24)
-
A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients
Authors (first, second and last of 16)
-
Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMT
Authors (first, second and last of 13)
-
Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair
Authors (first, second and last of 19)
-
Eculizumab treatment: stochastic occurrence of C3 binding to individual PNH erythrocytes
Authors (first, second and last of 6)
